Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

EU Joint Clinical Assessment (JCA) – Implications for Pharma and Medtech

Katie Rose (Consultant – Market Access), Maria Dimitrova (Consultant – HTA) and Samantha Gillard (Director – HTA) provide an overview of the EU Joint Clinical Assessment (JCA) and what it...

Petauri Evidence

- PMLiVE

Movember 2024 – Men’s Health

This Movember, Innovative Trials are raising awareness about men’s health issues like prostate cancer, testicular cancer, and mental health.

Innovative Trials

- PMLiVE

Merck gains rights to LaNova’s PD-1/VEGF bispecific antibody in deal worth over $3.2bn

A phase 1 clinical trial of the candidate in advanced solid tumours is currently enrolling patients

- PMLiVE

European Medicines Group appoints Rippon Ubhi as chair

Ubhi will maintain her role as country lead for Sanofi UK and Ireland

- PMLiVE

Creative strategy in medical communications

By Georgia Hartnell

- PMLiVE

GSK and Vesalius partner on new Parkinson’s treatments in deal worth $650m

The alliance is aimed at developing treatments for Parkinson's and another neurodegeneration indication

- PMLiVE

ICR researchers identify potential treatment approach for acute myeloid leukaemia

More than 3,100 people are diagnosed with the aggressive blood cancer in the UK every year

- PMLiVE

Cutting through the maze of obstacles to liberate patient pathways

Digital and AI intelligence – advancing healthcare and demolishing access and equity barriers

- PMLiVE

Don’t miss out! Get a Sneak Peek at Next-Gen Life Science Education and Training Tools

From interactive case studies to AI-driven avatars, our free webinar dives into the tools defining tomorrow’s life sciences education. Last spots available – sign up now!

Impetus Digital

- PMLiVE

Novartis and Schrödinger to advance drug candidates in deal worth over $2.4bn

The companies will advance therapeutics for undisclosed targets in Novartis’ core areas

- PMLiVE

Merck KGaA/Abbisko share positive phase 3 results for pimicotinib in rare tumour type

The companies entered into a licensing agreement for the candidate in December last year

- PMLiVE

Is Gen AI ready for life sciences?

The explosive growth of Gen AI has caused plenty of consternation as well as celebration, but there’s no turning back the clock on this far-reaching technology

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links